Clinical Trial Update: COgnitioN With VERiciGuat Evaluation in Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cognition with vericiguat in patients with heart failure is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Heart Failure

Drugs mentioned

• Verquvo (vericiguat)

Snippet

Sponsor: University of Alberta | Conditions: Heart Failure, Cognitive Impairment | Phase 2 | Status: RECRUITING